Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003

MeSH terms

• Blood Volume / drug effects
• Clinical Trials as Topic
• Comorbidity
• Contraindications
• Diabetes Mellitus, Type 2 / complications
• Diabetes Mellitus, Type 2 / drug therapy*
• Diabetes Mellitus, Type 2 / physiopathology
• Drug Therapy, Combination
• Edema / chemically induced*
• Edema / physiopathology
• Glyburide / therapeutic use
• Heart Failure / chemically induced
• Heart Failure / epidemiology
• Heart Failure / etiology*
• Heart Failure / physiopathology
• Heart Failure / prevention & control
• Humans
• Hypoglycemic Agents / adverse effects*
• Hypoglycemic Agents / therapeutic use
• Insulin / administration & dosage
• Insulin / therapeutic use
• Metformin / administration & dosage
• Metformin / therapeutic use
• Risk Factors
• Safety
• Thiazolidinediones / administration & dosage
• Thiazolidinediones / adverse effects*
• Thiazolidinediones / therapeutic use
• Weight Gain / drug effects